When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Back in 2018, a Tampa woman named Gabrielle Hartley faced every dog parent’s worst nightmare. Her beloved Husky, Luca, was stolen right from her home. Yet through all the heartbreak, she never lost ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.41187 EPS, ...

Ray tracing and path tracing sound similar — and technically, they are. Both methods simulate how light travels in a 3D environment, but the way they work and the results they produce are completely ...

How to Find the Owner of a VoIP Number: Easy Lookup Methods Your email has been sent Key takeaways: Voice-over-Internet-Protocol (VoIP) is a technology that enables ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...